UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):    October 27, 2010
 
PACIFICHEALTH LABORATORIES, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation)
 
000-23495
 
22-3367588
(Commission File Number)
 
(IRS Employer Identification No.)

100 Matawan Road, Suite 420 Matawan, NJ
 
07747-3913
(Address of Principal Executive Offices)
 
(Zip Code)

(732) 739-2900
(Registrant’s Telephone Number, Including Area Code)
 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
Item 2.02      Results of Operations and Financial Condition.
 
On October 27, 2010, PacificHealth Laboratories, Inc. issued a press release announcing certain financial results for the quarter ended September 30, 2010. The full text of the press release is attached hereto as Exhibit 99.1 to this Current Report on. Form 8-K.
 
Section 9 – Financial Statements and Exhibits
 
(c)
Exhibits.
   
99.1
Press release October 27, 2010.
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
PACIFICHEALTH LABORATORIES, INC.
     
Dated: October 27, 2010
By:
/s/ Stephen P. Kuchen
   
Stephen P. Kuchen
Chief Financial Officer

 
 
 
PacificHealth Laboratories (CE) (USOTC:PHLI)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse PacificHealth Laboratories (CE)
PacificHealth Laboratories (CE) (USOTC:PHLI)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse PacificHealth Laboratories (CE)